Literature DB >> 24057714

Semen quality and gonadotropin levels in patients operated upon for cryptorchidism.

J Mayr1, H H Pusch, G Schimpl, T Reitinger, E Sorantin, M Mayr-Koci.   

Abstract

In a long-term follow-up study we compared preoperative testicular position, age at orchiopexy, and morphology of testicular biopsies investigated at orchiopexy to sperm analysis results, testicular volume, and serum follicle-stimulating hormone and luteinizing hormone levels at follow-up in 46 men with a history of surgical correction of cryptorchidism in childhood. They had undergone orchiopexy at age 1.5-12.0 years, 24 for unilateral and 22 for bilateral cryptorchidism. Eleven (46%) of the 24 patients with unilateral and 7 (32%) of the 22 with bilateral undescended testes had a normal sperm analysis, whereas in men with impaired spermiogenesis oligo-asthenozoospermia was the predominant feature. Three (13.6%) patients with bilateral cryptorchidism showed azoospermia, but none of the patients with unilateral cryptorchidism did. Neither the age at orchiopexy nor the average germ-cell count per cross-sectioned seminiferous tubule of testicular biopsies examined at orchiopexy correlated significantly with subsequent sperm analysis results or gonadotropin levels at follow-up. The pretreatment testicular position ("testicular position value") has a high prognostic value for prediction of subsequent sperm analysis results and serum gonadotropin levels.

Entities:  

Year:  2013        PMID: 24057714     DOI: 10.1007/BF00497811

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  24 in total

1.  Semen analysis of patients who had orchidopexy at or after seven years of age.

Authors:  P Puri; B O'Donnell
Journal:  Lancet       Date:  1988-11-05       Impact factor: 79.321

2.  Staged orchiorrhaphy. Therapeutic procedure in cryptorchic testicle with a short spermatic cord.

Authors:  M Zer; Y Wolloch; M Dintsman
Journal:  Arch Surg       Date:  1975-04

3.  Gonadotropins, testosterone and prolactin in men with abnormal semen findings and an evaluation of the hormone profile.

Authors:  L Abramsson; M Duchek
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

4.  Ultrasonic testicular texture and size in 444 men from the general population: correlation to semen quality.

Authors:  S Lenz; A Giwercman; A Elsborg; K H Cohr; J E Jelnes; E Carlsen; N E Skakkebaek
Journal:  Eur Urol       Date:  1993       Impact factor: 20.096

5.  Primary testicular disease presenting as azoospermia or oligozoospermia in an infertility clinic.

Authors:  A M Jequier; S C Holmes
Journal:  Br J Urol       Date:  1993-06

6.  Fertility prospects for children with cryptorchidism.

Authors:  P E Gilhooly; F Meyers; J K Lattimer
Journal:  Am J Dis Child       Date:  1984-10

7.  Long-term follow-up of fertility in cryptorchid patients.

Authors:  B Fallon; T J Kennedy
Journal:  Urology       Date:  1985-05       Impact factor: 2.649

8.  The incidence of antisperm antibodies in infertility patients with a history of cryptorchidism.

Authors:  R L Urry; D T Carrell; N T Starr; B W Snow; R G Middleton
Journal:  J Urol       Date:  1994-02       Impact factor: 7.450

9.  Examination for intratubular germ cell neoplasia at operation for undescended testis in boys.

Authors:  D Cortes; J Thorup; M Frisch; H Møller; G K Jacobsen; B L Beck
Journal:  J Urol       Date:  1994-03       Impact factor: 7.450

10.  Exocrine and endocrine testicular function in patients with unilateral testicular disease.

Authors:  K Scheiber; H Marberger; G Bartsch
Journal:  J R Soc Med       Date:  1983-08       Impact factor: 18.000

View more
  2 in total

Review 1.  Germ cell development in the descended and cryptorchid testis and the effects of hormonal manipulation.

Authors:  C Ong; S Hasthorpe; J M Hutson
Journal:  Pediatr Surg Int       Date:  2005-02-23       Impact factor: 1.827

2.  Clinical aspects of histological and hormonal parameters in boys with cryptorchidism: Thesis for PhD degree.

Authors:  Simone Engmann Hildorf
Journal:  APMIS       Date:  2022-07       Impact factor: 3.428

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.